Dasatinib Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 20 mg, 50 mg, 70 mg, 100 mg, 140 mg

Reference Brands: Sprycel® (EU & US)

Category: Oncology Cancer Care

Dasatinib is available in Tablet and strengths such as 20 mg, 50 mg, 70 mg, 100 mg, 140 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Dasatinib is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Dasatinib can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Dasatinib is an oral tyrosine kinase inhibitor (TKI) used to treat Philadelphia chromosome-positive chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL). By targeting the BCR-ABL fusion protein, Dasatinib effectively blocks the signals that drive the growth of cancer cells. Available in tablet forms of 20 mg, 50 mg, 70 mg, 100 mg, and 140 mg, it offers a flexible dosing regimen for oncologists. Sprycel® (Dasatinib) is widely available in both the US and EU, providing essential treatment options for leukemia patients. This presents significant B2B opportunities for pharmaceutical manufacturers in these markets.